Evidence map›Paper›PMID 41970522›Full record

ArticleFrontiers in digital health2026

Prediction of maturity-onset diabetes of the young subtypes using machine learning.

Israel Figueroa, Ricardo Flores, Andrea Millán, Alejandro de Dios, Gustavo Daniel Frechtel, Ariel Pablo López, Daniela Mennickent

Abstract read
In one paragraph

Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Israel FigueroaFacultad de Ingeniería, Universidad Católica de la Santísima Concepción, Concepción, Chile.
Ricardo FloresDepartamento de Ingeniería Informática y Ciencias de la Computación, Facultad de Ingeniería, Universidad de Concepción, Concepción, Chile.
Andrea MillánCátedra de Genética, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Alejandro de DiosDivisión Nutrición, Hospital de Clínicas, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
Gustavo Daniel FrechtelDivisión Nutrición, Hospital de Clínicas, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
Ariel Pablo LópezCátedra de Genética, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Daniela MennickentDepartamento de Ciencias Básicas y Morfología, Facultad de Medicina, Universidad Católica de la Santísima Concepción, Concepción, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Maturity-onset diabetes of the young (MODY) is a monogenic type of diabetes caused by different pathogenic genetic variants in glucose metabolism-related genes, with GCK-MODY and HFN1A-MODY subtypes being the most frequent. Diagnosing the specific MODY subtype is essential for correct treatment and follow-up, but it requires gene sequencing, a time-consuming and costly process that depends on highly skilled professionals. Therefore, it is mandatory to develop tools that allow to correctly determine in which order to study the involved genes, reducing the number of sequencing procedures to find the causal variant and making the diagnostic process more efficient. This proof-of-concept study evaluates machine learning as a complement to clinical characterization and genetic testing, by optimizing binary classification models for explainable prediction of MODY subtypes, with a focus on GCK-MODY and HFN1A-MODY. Methods: To meet this aim, we analyzed medical data from a diabetes cohort from Buenos Aires, Argentina. By employing imputation and oversampling techniques we created 10 datasets for each subtype to feed a pipeline that trained, optimized and evaluated 10 machine learning techniques. Results: Gaussian Naive Bayes achieved the best predictive power for GCK-MODY with a ROC AUC score of 0.724, meanwhile Random Forest yielded 0.712 for HNF1A-MODY. SHAP analysis provided insights into feature importance, highlighting the explainability of our approach. Discussion and conclusion: This novel study demonstrates for the first time the viability of machine learning as a supplementary tool prior to MODY genetic testing, by providing cost-effective and explainable models able to assist health professionals in the diagnosis of MODY subtypes.

Indexed as

classificationdiabetesexplainable AImachine learningMODYsubtypes

Identifiers

PMID41970522
PMCPMC13062332

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.